Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in high-risk occupational population.
Yao T, Guo Y, Xu X, Zhang X, Mu S, Huo J, Wei Z, Liu L, Li X, Li H, Xing R, Feng Y, Chen J, Feng L, Wang S.
Yao T, et al.
Vaccine. 2023 Sep 15;41(40):5910-5917. doi: 10.1016/j.vaccine.2023.08.042. Epub 2023 Aug 19.
Vaccine. 2023.
PMID: 37604725
Clinical Trial.